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Improvement of survival in Polish stroke patients is 
related to reduced stroke severity and better control  
of risk factors: the Krakow Stroke Database
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A b s t r a c t
Introduction: In the last decade, the stroke mortality rate in Poland signifi-
cantly decreased. We hypothesised that stroke severity, the major determi-
nant of outcome, is lowered in Polish stroke patients. 
Material and methods: We compared the stroke severity in two cohorts of 
first-ever ischaemic stroke patients admitted within 24 h after stroke onset 
to the Department of Neurology, Jagiellonian University, Krakow in the years 
1994–2000 and 2008–2012. To assess stroke severity we used the National 
Institute of Health Stroke Scale (NIHSS). We defined mild stroke as an NIHSS 
score ≤ 4.
Results: We included 816 patients hospitalised in the years 1994–2000 and 
569 patients hospitalised in the years 2008–2012. NIHSS score on admis-
sion was higher in the former (mean: 12.0 ±7.0 vs. 8.0 ±6.0, p < 0.01), and 
the frequency of mild stroke was higher in the latter (12.7% vs. 41.8%, p < 
0.01). Although the frequency of hypertension (67.3% vs. 81.2%, p < 0.01), 
diabetes mellitus (20.8% vs. 26.4%, p = 0.02) and atrial fibrillation (20.7% 
vs. 26.2%, p = 0.02) was higher in patients hospitalised in the years 2008–
2012, the systolic and diastolic blood pressure values and the frequency 
of fasting hyperglycaemia were lower in this cohort. This cohort also less 
frequently suffered from hypercholesterolaemia (25.4% vs. 16.3%, p < 0.01).
Conclusions: Reduced stroke severity is associated with better recognition 
and control of risk factors and explains the improvement of survival in Polish 
stroke patients. 
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Introduction
Epidemiological and hospital-based studies conducted in the 1990s 
showed a higher mortality rate in Polish stroke patients compared to 
patients from the USA or western European countries [1–3]. In the War-
saw Stroke Registry, 30-day and 1-year case fatality rates in the years 
1991–1992 were 43% and 59.7%, respectively. This excessive stroke 
mortality was attributed, at least partially, to more severe stroke and 
higher frequency of cardiovascular diseases (hypertension, atrial fibril-
lation, diabetes, coronary heart disease, heart failure) in the Polish pop-
ulation [4]. 
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In the last two decades the death rate from cor-
onary heart disease in Poland halved [5–8]. This 
reduction was attributed to favourable changes in 
cardiovascular risk factors (~54% fall) and modern 
treatments (~37% fall) [8]. In the last decade a sig-
nificant decrease in mortality rates was observed 
in Polish stroke patients [9, 10]. According to the 
European Register of Stroke Project, 30-day case 
fatality in the Warsaw population in the year 2005 
was 14.9% and 1-year case fatality was 33.1%.
We hypothesised that reduced stroke mortality 
in Polish patients could be related to decreased 
stroke severity, which is the major determinant of 
outcome in stroke patients. 
Material and methods
Using our stroke database, we compared the 
baseline characteristics of the cohort of patients 
hospitalised in the Department of Neurology, Jagiel- 
lonian University, Krakow in the years 1994–2000 
and the cohort of patients hospitalised in the 
years 2008–2012. Consecutive patients with 
first-ever ischaemic stroke admitted to our stroke 
unit within 24 h after stroke onset were eligible 
for the study. The cohort of patients hospitalised 
in the years 1994–2000 included 816 persons and 
the cohort of patients hospitalised in the years 
2008–2012 included 569 persons.
All patients underwent head computed tomog-
raphy (CT) scan within 24 h after stroke onset. We 
assessed stroke severity using the Scandinavian 
Stroke Scale (SSS) [11] for patients hospitalised in 
the years 1994–2000 and the National Institute 
of Health Stroke Scale (NIHSS) [12] for patients 
hospitalised in the years 2008–2012. Nowadays 
NIHSS is routinely used in clinical practice; how-
ever, for long time this scale was used mainly in 
the United States, whereas European countries 
tended to use the SSS. To facilitate the compar-
isons between groups, we converted SSS scores 
to NIHSS scores using a published mathematical 
equation [13]. A  previous study demonstrated 
that total scores for SSS and NIHSS may be in-
terconverted with good precision [13]. We defined 
mild stroke as an NIHSS score ≤ 4. This threshold 
has been commonly used in previous studies on 
thrombolysis in stroke patients [14].
Arterial hypertension was diagnosed when its 
presence was documented in medical records or 
when at least 2 readings of blood pressure were 
≥ 140 mm Hg (systolic) or ≥ 90 mm Hg (diastolic) 
after the acute phase of stroke. Diabetes mellitus 
was diagnosed if its presence was documented in 
medical records or the patient was taking insulin 
or oral hypoglycaemic agents. Hypercholesterolae-
mia was defined as a fasting total cholesterol level 
> 6.1 mmol/l. Fasting hyperglycaemia was defined 
as a serum glucose level > 6.1 mmol/l. The glomer-
ular filtration rate (GFR) was estimated from the 
Modification of Diet in Renal Disease equation.
The study protocol was approved by the 
Bioethics Committee of Jagiellonian University 
(120/B/2012).
Statistical analysis
The c2 test was used to compare proportions 
and the Mann-Whitney test to compare continu-
ous variables between groups. The calculations 
were performed using the program Statistica for 
Windows (version 10, StatSoft, Poland).
Table I. Characteristics of two stroke patient cohorts
Parameter Cohort 1994–2000  
(N = 816)
Cohort 2008–2012  
(N = 569)
P-value
Age, mean ± SD 69.6 ±12.6 70.4 ±13.4 0.23
Female, n (%) 431 (52.8) 296 (52.0) 0.77
Hypertension, n (%) 549 (67.3) 462 (81.2) < 0.01
Diabetes mellitus, n (%) 170 (20.8) 150 (26.4) 0.02
Previous myocardial infarction, n (%) 104 (12.7) 80 (14.1) 0.48
Atrial fibrillation, n (%) 169 (20.7) 149 (26.2) 0.02
Hypercholesterolaemia, n (%) 207 (25.4) 93 (16.3) < 0.01
TIA prior to stroke, n (%) 68 (8.3) 30 (5.3) 0.03
NIHSS score on admission, mean ± SD 12.0 ±7.0 8.0 ±6.0 < 0.01
Mild stroke, n (%) 104 (12.7) 238 (41.8) < 0.01
30-day case fatality, n (%) 134 (16.4) 30 (5.3) < 0.01
Systolic blood pressure on admission, mean ± SD 161 ±29 151 ±26 < 0.01
Diastolic blood pressure on admission, mean ± SD 94 ±16 87 ±14 < 0.01
Fasting hyperglycaemia, n (%) 333 (40.8) 180 (31.6) < 0.01
GFR < 60 ml/min per 1.73 m2, n (%) 300 (36.7) 115 (20.2) < 0.01
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Results
The characteristics of both cohorts are shown 
in Table I.
The patients hospitalised in the years 1994-
2000 had a  significantly higher NIHSS score on 
admission than those hospitalised in the years 
2008–2012. The proportion of mild stroke was 
lower in the former. NIHSS scores are shown in 
Figure 1. 
The distribution of risk factors and cardiovas-
cular diseases was different between groups. The 
patients hospitalised in the years 2008–2012 
more often had diagnosed hypertension, diabetes 
mellitus and atrial fibrillation than the patients 
hospitalised in the years 1994–2000. Those hos-
pitalised in the years 1994–2000 more often suf-
fered from hypercholesterolaemia and transient 
ischaemic attack (TIA) prior to stroke. 
Both systolic and diastolic blood pressure values 
were higher on admission in the patients hospital-
ised in the years 1994–2000 than in those hospi-
talised in the years 1998–2012. The former more 
frequently had GFR below 60 ml/min per 1.73 m2 
and more often had fasting hyperglycaemia. 
Finally, 30-day case fatality was lower in the pa-
tients hospitalised in the years 2008–2012.
Discussion
We found decreased stroke severity reflected 
by a  lower NIHSS score in the patients hospital-
ised in the years 2008–2012 compared with those 
hospitalised in the years 1994–2000. Stroke se-
verity is the most important predictor of outcome. 
Thus, reduction in stroke severity could explain, at 
least partially, the lower case fatality observed by 
us in Polish stroke patients. 
Paradoxically, the frequency of major risk fac-
tors (hypertension, diabetes mellitus, atrial fibril-
lation) was higher in the cohort hospitalised in the 
years 2008–2012. The exception was hypercholes-
terolaemia, which was less frequent in this cohort. 
Also the frequency of TIAs before stroke was lower 
in this group of patients. Higher frequency of ma-
jor risk factors in the cohort hospitalised in the 
years 2008–2012 could be explained by better 
recognition and treatment of cardiovascular dis-
eases in Poland in recent years [8]. We observed 
significantly lower values of both blood pressure 
on admission and fasting glucose in the patients 
hospitalised in the years 2008–2012. Although 
blood pressure and glucose level measured in 
acute stroke depend partially on stroke severity, 
their lower values also reflect better control of 
hypertension and hyperglycaemia before stroke. 
Furthermore, higher values of glomerular filtration 
rate (GRF), the recognised marker of subclinical or-
gan damage in hypertension, in the patients hos-
pitalised in the years 2008–2012 suggest better 
control of blood pressure in this group of patients. 
Lower frequency of hypercholesterolaemia in 
patients hospitalised in the years 2008–2012 could 
be related to changes in dietary habits and/or more 
common use of statins. A  reduction of total cho-
lesterol was observed in the last decades in the 
Polish population and was attributed to increased 
consumption of oils rich in α-linolenic acid [5–8].
Our study has several limitations. First, it was 
a  single centre study, and our results do not nec-
essarily reflect the epidemiological situation in the 
whole Polish population. Second, the conversion of 
SSS scores to NIHSS scores is not perfect, although 
a  previous study showed satisfactory precision 
of this method [13]. Third, our study is not able to 
demonstrate causality between risk factors and 
stroke severity. Finally, we cannot verify the hypothe-
sis that reduced stroke severity in our stroke patients 
may be related to more common use of statins and 
ACE inhibitors, drugs that could exert a  neuropro-
tective effect [15–18]. Our database did not contain 
information about medications taken before stroke. 
In conclusion, we observed a decrease of stroke 
severity among Polish patients hospitalised in re-
cent years. The reduction in stroke severity was 
associated with better recognition and control of 
risk factors, which highlights the significance of 
primary prevention. However, it should be empha-
sised that the optimal blood pressure and choles-
terol levels to optimise stroke prevention remain 
largely unknown [19, 20].
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